Description
Sorafenib Tosylate is an inhibitor of Flk-1 (VEGFR), PDGFR and Raf kinases used for the treatment of human hepatocellular carcinoma.
Molecular Formula
C21H16ClF3N4O3•C7H8SO3
Solubility
Soluble in water
SMILES
CC1=CC=C(C=C1)S(=O)(=O)[O-].CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
Boiling Point
523.3ºC at 760 mmHg
IC50
Melanocortin receptor 4: IC50 = 4.48 µM (human); Raf-1: IC50 = 6 nM; B-Raf: IC50 = 22 nM; VEGFR2: IC50 = 90 nM; mVEGFR2 (flk-1): IC50 = 15 nM; mVEGR-3: IC50 = 20 nM
Preparation Use
A small molecular inhibitor of VEGFR, PDGFR, c-Raf and B-Raf, used in advanced liver cancer treatment and is well tolerated.
Qualification
ASMF/CEP/USMF